
Course Introduction: MHRA Medical Devices Registration – Before & After Brexit (UK & Ireland)
The regulatory landscape for medical devices in the United Kingdom and Ireland has changed dramatically in recent years. With the historic impact of the Brexit, manufacturers, regulatory professionals, and healthcare companies must now navigate a completely new regulatory framework for placing medical devices on the market.
Understanding how to register medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA) has become an essential skill for anyone working in regulatory affairs, quality assurance, or the medical device industry.
In this practical and career-focused course, you will learn step-by-step how medical device registration worked before Brexit and how it works today, including the latest UK regulatory requirements and the relationship between UK, EU, and Irish regulatory systems.
Throughout this course, we will explore:
The UK regulatory framework before Brexit
What changed after Brexit for medical device manufacturers
How to register medical devices with the MHRA
The role of UK Responsible Persons
Market access requirements for Great Britain, Northern Ireland, and Ireland
Differences between UKCA and CE marking
Practical strategies for successful device registration and market entry
By the end of the course, you will gain practical regulatory knowledge that is highly valuable in the global medical device industry, enabling you to support companies seeking market access in the UK and Ireland.
Whether you are a pharmacist, regulatory affairs professional, medical device specialist, quality professional, or a student aiming to build a career in the life sciences industry, this course will provide you with the essential regulatory expertise needed to confidently navigate the post-Brexit regulatory environment.
? Join this course today and gain the knowledge that regulatory professionals need to successfully register and commercialize medical devices in the UK and Ireland.
MHRA Guidelines
Understanding regulatory guidelines is essential for anyone working with medical devices in the UK market. In this module, we will explore the key guidance and regulatory requirements issued by the Medicines and Healthcare products Regulatory Agency (MHRA), the authority responsible for ensuring that medical devices placed on the UK market meet the highest standards of safety, quality, and performance.
The regulatory landscape for medical devices in the United Kingdom has evolved significantly, especially following the impact of Brexit. As a result, manufacturers and regulatory professionals must understand how MHRA guidelines apply to medical device registration, compliance, and market access within Great Britain and Northern Ireland.
In this module, you will gain a clear understanding of the most important MHRA guidelines that manufacturers and regulatory professionals must follow. We will review the regulatory framework governing medical devices in the UK and explain how these guidelines help ensure product safety, regulatory compliance, and successful device registration.
By the end of this module, you will be able to:
Understand the role of MHRA in regulating medical devices
Identify the key MHRA guidelines and regulatory requirements
Understand how these guidelines support device safety and market authorization
Apply MHRA guidance when preparing medical device registration and compliance strategies
This module will provide you with the foundational regulatory knowledge needed to confidently navigate MHRA guidance and successfully prepare for medical device registration in the UK market.
MHRA Foundations
Welcome to the MHRA Foundations module, where we will build the essential knowledge needed to understand how medical devices are regulated in the United Kingdom. Before learning about the registration process, it is crucial to first understand the regulatory authority responsible for overseeing the safety, quality, and performance of medical devices placed on the UK market.
In this module, we will introduce the role and responsibilities of the Medicines and Healthcare products Regulatory Agency (MHRA), the organization that regulates medicines and medical devices in the United Kingdom. The MHRA ensures that products used by patients and healthcare professionals meet strict standards of safety, effectiveness, and quality.
We will also explore how the regulatory framework evolved after the major political change of Brexit, which significantly reshaped medical device regulations in the UK. Understanding these changes is essential for regulatory professionals, manufacturers, and anyone involved in bringing medical devices to the UK market.
During this module, you will learn about:
The role and responsibilities of the MHRA
The structure of the UK medical device regulatory system
Key terminology used in UK medical device regulations
The relationship between UK, EU, and Irish regulatory frameworks
How MHRA oversight protects patient safety and product quality
By the end of this module, you will have a strong regulatory foundation that will help you understand the more detailed processes covered later in the course, including medical device registration, compliance requirements, and post-market obligations in the UK.
This module will equip you with the fundamental knowledge needed to confidently navigate the UK medical device regulatory environment and begin your journey into MHRA regulatory compliance.
MHRA Milestones of Regulations and Guidelines
In order to understand the current medical device regulatory system in the United Kingdom, it is important to explore the key milestones that have shaped the development of regulations and guidelines over time. Regulatory frameworks do not evolve overnight; they are built through years of policy changes, legislative updates, and global healthcare needs.
In this module, we will explore the major regulatory milestones that have influenced medical device regulation under the authority of the Medicines and Healthcare products Regulatory Agency (MHRA). These milestones illustrate how the UK regulatory environment has progressed from alignment with European regulations to the development of its own national framework.
A major turning point in the regulatory landscape was the historic event of Brexit, which required the United Kingdom to establish new regulatory pathways for medical devices. This shift introduced important regulatory updates such as the UKCA marking system, new registration procedures, and updated guidance for manufacturers seeking access to the UK market.
Throughout this module, we will review the most significant regulatory developments, including:
The evolution of UK medical device legislation
Key MHRA regulatory guidance documents
The transition from EU regulatory alignment to UK-specific regulations
The introduction of UKCA marking and post-Brexit regulatory changes
Important timelines and milestones that manufacturers must understand
By the end of this module, you will have a clear understanding of how MHRA regulations and guidelines have evolved and how these milestones influence the current regulatory requirements for medical device registration and compliance in the UK market.
This historical and regulatory perspective will help you better understand the logic behind current requirements and prepare you to navigate the UK medical device regulatory framework with greater confidence.
The Actual Registration Journey with MHRA
Bringing a medical device to the UK market requires more than simply developing a safe and innovative product—it requires navigating a structured regulatory process to ensure compliance with national requirements. In this module, we will guide you through the actual registration journey for medical devices in the United Kingdom, providing a practical, step-by-step understanding of how manufacturers successfully register their products.
The registration process is managed by the Medicines and Healthcare products Regulatory Agency (MHRA), which oversees the regulation of medical devices to ensure they meet strict standards for safety, quality, and performance before they can be marketed and used by healthcare professionals and patients.
Following the regulatory changes introduced after Brexit, manufacturers must now follow updated UK-specific procedures when placing medical devices on the market in Great Britain, while also understanding the regulatory distinctions that apply to Northern Ireland.
In this module, we will walk through the practical registration pathway, explaining each stage of the process, including:
Determining device classification and regulatory pathway
Understanding UKCA and CE marking requirements
Appointing a UK Responsible Person (UKRP) when applicable
Preparing the required documentation for MHRA registration
Submitting the device through the MHRA registration system
Understanding timelines, fees, and regulatory expectations
Through practical explanations and real-world regulatory insights, this module will help you understand how companies move from product readiness to successful MHRA device registration.
By the end of this module, you will have a clear and structured understanding of the complete MHRA registration journey, allowing you to confidently support or manage medical device registration for the UK market.
Product Submission – Quality and QMS Requirements for MHRA
Successful medical device registration does not only depend on the device itself; it also requires manufacturers to demonstrate that their products are developed, manufactured, and controlled under a robust Quality Management System (QMS). Regulatory authorities expect manufacturers to maintain strong quality processes to ensure that medical devices consistently meet safety, performance, and regulatory requirements.
In this module, we will explore the quality and QMS elements that support medical device product submissions to the Medicines and Healthcare products Regulatory Agency (MHRA). Understanding these requirements is essential for manufacturers seeking to place medical devices on the UK market.
A well-established QMS ensures that every stage of the device lifecycle—from design and development to manufacturing, distribution, and post-market monitoring—is managed according to internationally recognized quality standards. Regulatory submissions often require evidence that the manufacturer operates under a compliant quality framework, most commonly aligned with the principles of ISO 13485 for medical devices.
Throughout this module, we will examine the key quality components that support MHRA device registration, including:
The role of Quality Management Systems (QMS) in medical device compliance
Key elements of ISO 13485 and quality documentation
Quality procedures required for design, manufacturing, and control
How QMS evidence supports product submission and regulatory compliance
The relationship between quality systems, technical documentation, and regulatory approvals
By the end of this module, you will understand how quality systems and regulatory submissions work together to demonstrate that a medical device is safe, reliable, and compliant with UK regulatory expectations.
This module will help you connect quality management practices with regulatory success, giving you practical insight into how manufacturers prepare the quality documentation that supports MHRA medical device registration and market access in the UK.
Module 1 Specifications, Cases, and Exemptions
In this section, we will take a deeper look into Module 1, exploring its detailed requirements, specific cases, and the situations where exemptions may apply. Module 1 is often one of the most debated and challenging parts of the regulatory framework because its applicability can vary depending on the type and classification of the medical device.
In practice, not all regulatory requirements under Module 1 apply equally to every product. This is particularly relevant for simple or lower-risk medical devices, where certain regulatory elements may be reduced, adapted, or exempted based on the device classification and regulatory pathway.
Throughout this module, we will clarify how Module 1 requirements are interpreted in real regulatory scenarios. We will analyze practical cases, regulatory expectations, and possible exemptions, helping you understand when specific requirements apply and when they may not be necessary.
By the end of this section, you will gain a clearer understanding of how to navigate Module 1 requirements efficiently, avoid unnecessary regulatory burden, and correctly determine which provisions apply to your medical device submission.
In this section, we will practice the after-registration activities, starting with exploring the variations with MHRA and how to submit for those variations
In this section, we will have a short flight trip to the Northern Island and see and compare regulations of medical devices there to those of MHRA, and what is applicable and what is not
In this section, we will have a look at the updated regulations set by MHRA after Brexit, why Brexit? And what's going to happen after it
Master medical devices registration in the most important and biggest market ever in the world, the market of UK, this market could be missed by any pharmaceutical or healthcare company; all the pharma industry professionals understand very well the weight of this market, how huge it is, and what the expected revenue out of it.
The MHRA (Medicines and Healthcare Products Regulatory Agency) is the UK's regulatory body responsible for ensuring that medicines, medical devices, and blood components for transfusion meet applicable safety, efficacy, and quality standards. It operates under the Department of Health and Social Care (DHSC) and plays a key role in regulating pharmaceuticals post-Brexit.
What will you learn?
Product registration with MHRA
Master Regulatory Affairs processes of MHRA
The best regulatory pathway for the best product
Handling and matching MHRA regulatory pathways
Comparing the UK, Britain, to Ireland's regulations
Which is the leader of the Great Britain region when it comes to regulations
What Ireland follows, and does not follow, with MHRA
MHRA before and after Brexit
In this course, we will be introduced to the details of MHRA regulations, considering Brexit & UK Regulatory Framework
Since Brexit, the UK has followed its regulatory framework, separate from the European Medicines Agency (EMA).
Great Britain (England, Scotland, Wales) follows MHRA rules.
Northern Ireland still follows EMA regulations under the Northern Ireland Protocol.
We will master MHRA Regulatory Pathways
National Procedure (NP) – Full UK approval process for new medicines.
International Recognition Procedure (IRP) – Fast-track approval based on FDA, EMA, or other major agencies' decisions.
Innovative Licensing and Access Pathway (ILAP) – Accelerated pathway for innovative medicines (e.g., rare diseases, advanced therapies).
Rolling Review – Early engagement with MHRA for urgent treatments.
We will get introduced to MHRA Pharmacovigilance system: The Yellow Card Scheme
Yellow Card Scheme allows reporting of adverse drug reactions (ADRs), medical device failures, and counterfeit drugs.
Monitored by MHRA and the Commission on Human Medicines (CHM).
To have a global view of MHRA Collaboration & Global Role
Works with FDA (US), EMA (EU), WHO, and ICH for regulatory harmonization.
Active in Good Pharmacovigilance Practices (GVP) and International Coalition of Medicines Regulatory Authorities (ICMRA).
So, from a business point of view, you can place your product in the market quite faster and start earning your revenue quite fast also, moreover, the medical devices world is highly dynamic and innovative, compared to the pharmaceuticals, with lots of innovations and different versions of the same medical device could be played within the potential market of the UK.
Dear pharma industry future professionals, let us start our interesting journey toward medical device registration in the UK we will travel together to the UK, meet the health authority there "the MHRA, and explore its requirements for registration, renewal, and variations. Let us place our products there.
In this course, we will cover all topics related to medical devices in the UK, starting from the requirements, interim regulations, classification, verification, and special conditions.
Then we will go deeper to see the actual forms and templates as usual. I keep the theme of the Pharma Academy that it comes to you "From Practice", and prepare the submission dossier together, and ensure its verification, of the medical, and interact with the actual MHRA gateway for the submission.
and we will end our journey by landing the department of customs clearance, tracking /tracing system, barcoding, and 2DMatrix for all the shipments planned for the UK market importation.
And finally, congratulations to you for mastering medical device registration in the UK market, and see you soon in the pharma industry, my dear colleagues.
Why Enroll in This Course
Learn from real-world regulatory practice — not just theory.
Gain global insight as Health Canada aligns with FDA, EMA, WHO, and ICH standards.
Accelerate your company’s time-to-market with efficient submission strategies.
Enhance your professional credentials in regulatory affairs and market access.
Get access to practical templates, workflows, and case-based learning.
Take-Home Message
By the end of this course, you’ll be able to confidently manage medical device registration and post-market compliance in Canada — from dossier preparation to Health Canada approval — setting your business or career on the path to global regulatory excellence.
So fasten your seatbelt —
We’re taking off to UK , to unlock one of the most lucrative and respected healthcare markets in the world!
Let’s go!